Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27615609

CC(C)(C)OC=O.Clc1ccc(CC2CNC2)cc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A3 Q01959 3/20 0.38
TDP1 Q9NUW8 1/20 0.37
SSTR4 P31391 1/20 0.37
ALDH1A1 P00352 1/20 0.35
MAOB P27338 1/20 0.35
FPR2 P25090 1/20 0.34
PROKR1 Q8TCW9 1/20 0.34
REN P00797 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CTSD P07339 1/20 0.34
CTSE P14091 1/20 0.34
PGC P20142 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3914733 0.81 SLC6A4 (0.50) SLC6A4SLC6A2SLC6A3ALDH1A1MAOB
Tert-Butyl Formate SCHEMBL27668039 0.80 CMA1 (0.35) SLC6A4TDP1SSTR4ALDH1A1MAOB
Hydrochloric Acid SCHEMBL29090963 0.79 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3ALDH1A1MAOB
Tert-Butyl Formate SCHEMBL28024952 0.75 TDP1 (0.48) TDP1
Trifluoroacetic Acid SCHEMBL5224978 0.74 SLC6A2 (0.47) SLC6A4SLC6A2SLC6A3RENCYP3A4
Tert-Butyl Formate SCHEMBL27597018 0.73 MGLL (0.40) ALDH1A1
Tert-Butyl Formate SCHEMBL27993846 0.73 CXCR4 (0.48) TDP1ALDH1A1
Tert-Butyl Formate SCHEMBL28832674 0.72 MAP2K1 (0.46) SLC6A4SLC6A2SLC6A3
Tert-Butyl Formate SCHEMBL28314994 0.72 TDP1 (0.48) TDP1
Tert-Butyl Formate SCHEMBL27744083 0.72 TDP1 (0.48) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1638761-A Azetidine derivatives as CCR-3 receptor antagonists NOVARTIS AG (CH) 2005-07-13 CN disclosed